2m 2m 2m 2m 2m 2m 2m
Neogenomics (NEO)
NASDAQ
$14.16+$0.05 (+0.35%)
Price as of Jul 14, 2026 11:28 AM EDT- $1.8BMarket Cap
- 96.52%1-Year Change
- Diagnostics & ResearchIndustry
Neogenomics (NEO)
$14.16+$0.05 (+0.35%)
NEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.11 | ||
Change | $0.00 (0.00%) | ||
Open | $13.97 | ||
High | $14.24 | ||
Low | $13.85 | ||
Previous Close | $14.11 | ||
Volume | 1,543,181 | ||
30-Day Average Volume | 4,017,599 | ||
1-Week Change | -6.93% | ||
1-Month Change | 26.55% | ||
1-Year Change | 96.52% | ||
3-Year Change | -18.81% | ||
5-Year Change | -68.78% | ||
Fundamentals | |||
Shares Outstanding | 130.2M | ||
Total Assets | $1.3B | ||
Market Cap | $1.8B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $186.7M | ||
Net Income | -$17.1M | ||
Free Cash Flow | -$13.1M | ||
EBIT | -$17.6M | ||
EBITDA | -$9.9M | ||
Net Working Capital | $289.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -204 | ||
Enterprise Value/Revenue | 11 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -140 | ||
Price/Operating Cash Flow | -226 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue